CXCL1 and breast cancer: Additionally, in another study on 46 patients (age: 23–65) with BC (stage I, II, III, and IV) by immunohistochemistry, ELISA, and flow cytometry assays, it has been shown that Th17 cells regulate CXCL1 expression during cancer progression.